Fig. 2From: High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancerDemographic, clinical, and pathological features and ICR expressions on tumor-infiltrating CD8+ T cells (a), on tumor-infiltrating CD16+CD56dim NK cell subset (b), and LAG-3 expression on tumor infiltrating CD16-CD56bright NK cell subset (c)Back to article page